Methods for preventing and treating tissue damage associated with ischemiareperfusion injury

Details for Australian Patent Application No. 2004216176 (hide)

Owner Genentech, Inc.

Inventors Fung, Sek Chung

Agent Spruson & Ferguson

Pub. Number AU-B-2004216176

PCT Pub. Number WO2004/075837

Priority 60/449,069 21.02.03 US

Filing date 20 February 2004

Wipo publication date 10 September 2004

Acceptance publication date 3 April 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/075837 Priority application(s): WO2004/075837

3 April 2008 Application Accepted

  Published as AU-B-2004216176

17 April 2008 Assignment before Grant

  Tanox, Inc. The application has been assigned to Genentech, Inc.

31 July 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004216178-Chemical process for the preparation of intermediates to obtain N-formyl hydroxylamine compounds

2004216174-Craniofacial fracture reduction assembly